Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 4

2(28.6%)

N/A

2(28.6%)

Phase 1

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 4(2)

N/A(2)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06700018Recruiting

Flow Patterns and Stent Thrombosis

Role: collaborator

NCT07151976Recruiting

Thrombus Aspiration and Pathology and OCT Study

Role: lead

NCT07170475Phase 1Recruiting

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

Role: lead

NCT06508697Recruiting

CT-Angiography Plaque Characteristics and Events in Deferral Patients by Invasive Fractional Flow Reserve

Role: lead

NCT05117866Not ApplicableActive Not Recruiting

Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study

Role: collaborator

NCT04863131Phase 1Completed

Safety and Immunogenicity of EXG-5003

Role: lead

NCT02024230Phase 4Completed

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

Role: lead

NCT03292081Phase 2Unknown

Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation

Role: lead

NCT02972489Phase 4Unknown

Using 3D Imaging to Optimize Bifurcation Stenting

Role: collaborator

NCT00823537Not ApplicableUnknown

Power-Assisted Therapeutic Electrical Stimulation to Upper Extremities

Role: lead

All 10 trials loaded